Technology
Health
Biotechnology

NanoViricides

$0.2501
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0099 (-3.81%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NanoViricides and other stocks, options, ETFs, and crypto commission-free!

About

NanoViricides Inc., also called NanoViricides, is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. Read More The company was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.

Employees
30
Headquarters
Shelton, Connecticut
Founded
2000
Market Cap
17.38M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
191.79K
High Today
$0.2575
Low Today
$0.2434
Open Price
$0.2494
Volume
30.19K
52 Week High
$0.68
52 Week Low
$0.196

Collections

Technology
Health
Biotechnology
Therapy
Medical
US
North America

Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.03 per share
Actual
-$0.03 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.